SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001104659-21-102945
Filing Date
2021-08-10
Accepted
2021-08-10 17:11:06
Documents
11

Document Format Files

Seq Description Document Type Size
1 S-3 tm2124472-1_s3.htm S-3 641650
2 GRAPHIC lg_markertherapeutics-4clr.jpg GRAPHIC 57435
3 GRAPHIC tm2124472d1-tbl_bcm4clr.jpg GRAPHIC 47059
4 EXHIBIT 1.2 tm2124472d2_ex1-2.htm EX-1.2 268642
5 EXHIBIT 4.3 tm2124472d2_ex4-3.htm EX-4.3 382927
6 EXHIBIT 4.5 tm2124472d2_ex4-5.htm EX-4.5 120526
7 EXHIBIT 4.6 tm2124472d2_ex4-6.htm EX-4.6 137090
8 EXHIBIT 4.7 tm2124472d2_ex4-7.htm EX-4.7 107763
9 EXHIBIT 5.1 tm2124472d2_ex5-1.htm EX-5.1 30603
10 EXHIBIT 23.1 tm2124472d2_ex23-1.htm EX-23.1 2687
11 GRAPHIC tm2124472d2_ex5-1img01.jpg GRAPHIC 3048
  Complete submission text file 0001104659-21-102945.txt   1841725
Mailing Address 3200 SOUTHWEST FREEWAY SUITE 2500 HOUSTON TX 77027
Business Address 3200 SOUTHWEST FREEWAY SUITE 2500 HOUSTON TX 77027 (713) 400-6400
Marker Therapeutics, Inc. (Filer) CIK: 0001094038 (see all company filings)

IRS No.: 880277072 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-258687 | Film No.: 211160986
SIC: 2834 Pharmaceutical Preparations